These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

718 related articles for article (PubMed ID: 35644437)

  • 1. Uncovering the mechanism of Huanglian-Wuzhuyu herb pair in treating nonalcoholic steatohepatitis based on network pharmacology and experimental validation.
    Zhang X; Gao R; Zhou Z; Sun J; Tang X; Li J; Zhou X; Shen T
    J Ethnopharmacol; 2022 Oct; 296():115405. PubMed ID: 35644437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An herbal formulation "Shugan Xiaozhi decoction" ameliorates methionine/choline deficiency-induced nonalcoholic steatohepatitis through regulating inflammation and apoptosis-related pathways.
    Wang S; Chen B; Du R; Zhong M; Zhang C; Jin X; Cui X; Zhou Y; Kang Q; Xu H; Li Y; Wu Q; Tong G; Luo L
    J Ethnopharmacol; 2024 Jul; 329():118127. PubMed ID: 38583728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Huanglian-Hongqu herb pair improves nonalcoholic fatty liver disease via NF-κB/NLRP3 pathway in mice: network pharmacology, molecular docking and experimental validation.
    Wang Z; Qiu H; Yang Y; Zhang Y; Mou T; Zhang X; Zhang Y
    Hereditas; 2024 Apr; 161(1):12. PubMed ID: 38566171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction and verification of the active ingredients and potential targets of Erhuang Quzhi Granules on non-alcoholic fatty liver disease based on network pharmacology.
    Li S; Wu X; Ma Y; Zhang H; Chen W
    J Ethnopharmacol; 2023 Jul; 311():116435. PubMed ID: 37023836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological Mechanism of Ganlu Powder in the Treatment of NASH Based on Network Pharmacology and Molecular Docking.
    Gao R; Zhang X; Zhou Z; Sun J; Tang X; Li J; Zhou X; Shen T
    Dis Markers; 2022; 2022():7251450. PubMed ID: 35811658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring and Verifying the Mechanism and Targets of Shenqi Pill in the Treatment of Nonalcoholic Steatohepatitis via Network Pharmacology and Experiments.
    He B; Chen Z; Nie Y; Luo M; Xu S; Yan J; Chen Z
    J Immunol Res; 2022; 2022():6588144. PubMed ID: 35733920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
    Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
    J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of bioactive compounds and potential mechanisms of scutellariae radix-coptidis rhizoma in the treatment of atherosclerosis by integrating network pharmacology and experimental validation.
    Ji L; Song T; Ge C; Wu Q; Ma L; Chen X; Chen T; Chen Q; Chen Z; Chen W
    Biomed Pharmacother; 2023 Sep; 165():115210. PubMed ID: 37499457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YinChen WuLing powder attenuates non-alcoholic steatohepatitis through the inhibition of the SHP2/PI3K/NLRP3 pathway.
    Yuan X; Yang L; Gao T; Gao J; Wang B; Liu C; Yuan W
    Front Pharmacol; 2024; 15():1423903. PubMed ID: 39101141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring active ingredients and mechanisms of Coptidis Rhizoma-ginger against colon cancer using network pharmacology and molecular docking.
    Zeng T; Ling C; Liang Y
    Technol Health Care; 2024; 32(S1):523-542. PubMed ID: 38759074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Effect and Mechanism Prediction of Fuzi-Gancao Herb Couple on Non-alcoholic Fatty Liver Disease (NAFLD) based on Network Pharmacology and Molecular Docking.
    Liu K; Yang X; Zhang G; Xiang Z
    Comb Chem High Throughput Screen; 2024; 27(5):773-785. PubMed ID: 37317908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential Molecular Mechanisms of Ephedra Herb in the Treatment of Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking.
    Yao T; Wang Q; Han S; Lu Y; Xu Y; Wang Y
    Biomed Res Int; 2022; 2022():9214589. PubMed ID: 35837376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network pharmacology-based prediction and validation of the active ingredients and potential mechanisms of the Huangxiong formula for treating ischemic stroke.
    Zhao S; Zhang P; Yan Y; Xu W; Li J; Wang L; Wang N; Huang Y
    J Ethnopharmacol; 2023 Aug; 312():116507. PubMed ID: 37080367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Jiangzhi Granule attenuates non-alcoholic steatohepatitis by suppressing TNF/NFκB signaling pathway-a study based on network pharmacology.
    Zhou W; Zhu Z; Xiao X; Li C; Zhang L; Dang Y; Ge G; Ji G; Zhu M; Xu H
    Biomed Pharmacother; 2021 Nov; 143():112181. PubMed ID: 34649337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the Effect of Xiao-Chai-Hu Decoction on Treating Psoriasis Based on Network Pharmacology and Experiment Validation.
    He K; Wang Z; Liu M; Du W; Yin T; Bai R; Duan Q; Wang Y; Lei H; Zheng Y
    Curr Pharm Des; 2024; 30(3):215-229. PubMed ID: 38532341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of network pharmacology and molecular docking technology reveals the mechanism of the herbal pairing of Codonopsis Pilosula (Franch.) Nannf and Astragalus Membranaceus (Fisch.) Bge on chronic heart failure.
    Xu J; Zhang Z; Zhou K; Li Y; Wan J; Mao T; Ji X; Liu J; Lin Q
    Ann Palliat Med; 2021 Jul; 10(7):7942-7959. PubMed ID: 34353081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Jingfang granule alleviates Pseudomonas aeruginosa-induced acute lung inflammation through suppression of STAT3/IL-17/NF-κB pathway based on network pharmacology analysis and experimental validation.
    Gu M; Su W; Dai J; Wang J; Jia X; Yao J; Zhang G; Zhu Q; Pang Z
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116899. PubMed ID: 37454750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Huangqin-Huanglian Decoction Protects Liver against Non-alcoholic Fatty Liver Disease in High Fat-diet Mice.
    Yang H; Wei D; Zhang Y; Jian W
    Endocr Metab Immune Disord Drug Targets; 2024; 24(6):691-708. PubMed ID: 37859322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network Pharmacology Study on Herb Pair
    Wang Y; Ding T; Jiang X
    Curr Pharm Des; 2024; 30(17):1354-1376. PubMed ID: 38571354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Network pharmacology, molecular docking and experimental verification of the mechanism of huangqi-jixuecao herb pair in treatment of peritoneal fibrosis.
    Dai H; Shan Y; Yu M; Wang F; Zhou Z; Sun J; Sheng L; Huang L; Sheng M
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116874. PubMed ID: 37437794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.